Unibest
← Back to patent-cliff list

CAS 918504-27-5

N-(3-(5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide

Codes: VEMF-008

Application context (from source-drug indications)

Erdheim-Chester diseaseVemurafenibMelanomaVemurafenibHistiocytosisVemurafenibLangerhans cell histiocytosisVemurafenibNon-Hodgkin lymphomaVemurafenibHepatoblastomaVemurafenib

Source drugs (routes using this intermediate)

DrugTierExpiry
VemurafenibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.